Skip to content

Deferred Taxes at other companies

Eli Lilly logo
Eli LillyLLY
$1.48B+277%
Pfizer logo
PfizerPFE
-$12M+98.2%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
-$968K-79.6%
Bioventus logo
BioventusBVS
$135K+214%
Avanos Medical logo
Avanos MedicalAVNS
$2.5M-19.4%

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's deferred taxes?
Dogwood Therapeutics (DWTX) reported deferred taxes of $1.19K in Q1 2026.
How has Dogwood Therapeutics's deferred taxes changed year-over-year?
Dogwood Therapeutics's deferred taxes decreased by 99.4% year-over-year, from $190.54K to $1.19K.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.